OPEN STUDIES
Actively Recruiting
Atopic Dermatitis
A Phase 3, 24-week, Randomized, Placebo-controlled, Double-blind Study to Assess the Efficacy, Safety and Tolerability of Rocatinlimab (AMG 451) Monotherapy in Adult Subjects With Moderate-to-severe Atopic Dermatitis (ROCKET)
Study Contact: Sonia Masuta
Chronic Spontaneous Urticaria
A randomized, double-blind, placebo-controlled, multi-center, parallel-group
studies of dupilumab in patients with chronic spontaneous urticaria (CSU) who remain symptomatic despite the use of H1 antihistamine treatment in patients naïve to omalizumab (CUPID)
Study Contact: Susi Snitzler
Peanut Allergy
A Phase 3, Double-blind, Placebo-controlled, Randomized Study to Assess the Efficacy and Safety of Epicutaneous Immunotherapy with DBV712 250 μg in 4-7-year-old Children with Peanut Allergy (VITESSE)
Study Contact: Anna De Jong
Active Studies - Non Recruiting
Please take a look at active studies that have been closed to recruiting
Past Studies
Please take a look at past studies that have been done.
Studies